Literature DB >> 11907818

Dofetilide block involves interactions with open and inactivated states of HERG channels.

Manjula Weerapura1, Terence E Hébert, Stanley Nattel.   

Abstract

Rapidly activating delayed rectifier current ( IKr) is the key target of class III antiarrhythmic drugs including dofetilide. Due to its complex gating properties, the precise channel state or states that interact with these agents remain poorly defined. We have undertaken a careful analysis of the state dependence of HERG channel block by dofetilide in Xenopus oocytes and Chinese Hamster Ovary (CHO) cells by devising a protocol in which brief sampling pulses were superimposed over a wide range of test potentials. The rate of block onset, maximal steady-state block and IC50 were similar for all test potentials over the activation range, demonstrating that the drug probably interacts with open and/or inactivated but not resting HERG channels with high affinity. Reducing the fraction of inactivated channels at 0 mV by augmenting the external potassium concentration did not alter the sensitivity to dofetilide. In contrast, the S631A and S620T HERG mutations both eliminated inward rectification and reduced dofetilide affinity by approximately 10- and approximately 100-fold respectively. We have also found a novel ultra-slow activation process which occurs in wild type HERG channels at threshold potentials. Overall, our data imply that dofetilide block occurs equally at all voltages positive to the activation threshold, and that the drug interacts with HERG channels in both the open and inactivated states.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11907818     DOI: 10.1007/s004240100720

Source DB:  PubMed          Journal:  Pflugers Arch        ISSN: 0031-6768            Impact factor:   3.657


  17 in total

1.  In silico screening of the impact of hERG channel kinetic abnormalities on channel block and susceptibility to acquired long QT syndrome.

Authors:  Lucia Romero; Beatriz Trenor; Pei-Chi Yang; Javier Saiz; Colleen E Clancy
Journal:  J Mol Cell Cardiol       Date:  2014-03-11       Impact factor: 5.000

2.  In silico screening of the impact of hERG channel kinetic abnormalities on channel block and susceptibility to acquired long QT syndrome.

Authors:  Lucia Romero; Beatriz Trenor; Pei-Chi Yang; Javier Saiz; Colleen E Clancy
Journal:  J Mol Cell Cardiol       Date:  2015-10       Impact factor: 5.000

3.  A comparison of currents carried by HERG, with and without coexpression of MiRP1, and the native rapid delayed rectifier current. Is MiRP1 the missing link?

Authors:  Manjula Weerapura; Stanley Nattel; Denis Chartier; Ricardo Caballero; Terence E Hébert
Journal:  J Physiol       Date:  2002-04-01       Impact factor: 5.182

4.  Blockade of HERG potassium currents by fluvoxamine: incomplete attenuation by S6 mutations at F656 or Y652.

Authors:  James T Milnes; Olivia Crociani; Annarosa Arcangeli; Jules C Hancox; Harry J Witchel
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

5.  Role of the activation gate in determining the extracellular potassium dependency of block of HERG by trapped drugs.

Authors:  Kristeen Pareja; Elaine Chu; Katrina Dodyk; Kristofer Richter; Alan Miller
Journal:  Channels (Austin)       Date:  2012-12-06       Impact factor: 2.581

6.  The 5-HT2 antagonist ketanserin is an open channel blocker of human cardiac ether-à-go-go-related gene (hERG) potassium channels.

Authors:  Q Tang; Z-Q Li; W Li; J Guo; H-Y Sun; X-H Zhang; C-P Lau; H-F Tse; S Zhang; G-R Li
Journal:  Br J Pharmacol       Date:  2008-06-23       Impact factor: 8.739

7.  Chlorthalidone inhibits the KvLQT1 potassium current in guinea-pig ventricular myocytes and oocytes from Xenopus laevis.

Authors:  C Mancilla-Simbro; A López; E Martinez-Morales; E Soto-Perez-de-Celis; L Millan-PerezPeña; R Tsushima; E M Salinas-Stefanon
Journal:  Br J Pharmacol       Date:  2007-11-26       Impact factor: 8.739

8.  An in vitro model for assessment of drug-induced torsade de pointes arrhythmia : effects of haloperidol and dofetilide on potential duration, repolarization inhomogeneities, and torsade de pointes arrhythmia.

Authors:  Stefan Dhein; Franziska Perlitz; Friedrich-Wilhelm Mohr
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-07-22       Impact factor: 3.000

9.  Action potential clamp and pharmacology of the variant 1 Short QT Syndrome T618I hERG K⁺ channel.

Authors:  Aziza El Harchi; Dario Melgari; Yi Hong Zhang; Henggui Zhang; Jules C Hancox
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

10.  A Computational Pipeline to Predict Cardiotoxicity: From the Atom to the Rhythm.

Authors:  Pei-Chi Yang; Kevin R DeMarco; Parya Aghasafari; Mao-Tsuen Jeng; John R D Dawson; Slava Bekker; Sergei Y Noskov; Vladimir Yarov-Yarovoy; Igor Vorobyov; Colleen E Clancy
Journal:  Circ Res       Date:  2020-02-24       Impact factor: 17.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.